Tildiem and renal failure Patient Reports February 12, 2012

Tildiem Side Effects Report #5281253-7
Tildiem side effect was reported by a Pharmacist from NETHERLANDS on Mar 08, 2007. Male patient, 81 years of age, was treated with Tildiem. After drug was administered, patient experienced the following side effects: dehydration, liver disorder, renal failure. Tildiem dosage: 200 MG QD PO. During the same period patient was treated with KEPPRA, FUROSEMIDE, THYRAX, CARBASALAT CALCIUM, CARBAMAZEPIN RETARD, DIPHANTOINE Z. Patient was hospitalized. Patient recovered.

Tildiem Side Effects Report #5293203-8
Tildiem side effect was reported by a Pharmacist from NETHERLANDS on Mar 20, 2007. Male patient, 81 years of age, was treated with Tildiem. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dehydration, hepatic function abnormal, liver disorder, metabolic encephalopathy, renal failure. Tildiem dosage: 200 MG QD; PO. During the same period patient was treated with KEPPRA, FUROSEMIDE, THYRAX, CARBASALAT CALCIUM, CARBAMAZEPIN RETARD, DIPHANTOINE Z. Patient was hospitalized. Patient recovered.

Tildiem Side Effects Report #4609714-1
Tildiem side effect was reported by a Consumer or non-health professional from on Feb 24, 2005. Female patient, 57 years of age, was treated with Tildiem. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, c-reactive protein increased, condition aggravated, nephritis interstitial, pco2 decreased, renal failure. Tildiem dosage: 60 MG TID PO. During the same period patient was treated with TRIATEC, INDOCIN, ARCALION, TARDYFERON, ESBERIVEN, PANTOPRAZOLE, LEXOMIL, INDOCOLLYRE. Patient was hospitalized. Patient recovered.